esqLABS
Software, Consulting and Workshops for Data Analysis and Model-Based Decision Support
ASCO 2020 Virtual Scientific Program, which took place 29 May – 2 June, reported results from clinical trials, highlighting a number of key developments in ovarian cancer treatment, which collectively show the value of innovative therapies in various patient subgroups, offering guidance to the treatment of recurrent ovarian cancer.
One of the highly anticipated presentations in ASCO 2020 was results from DESKTOP III/ENGOT-ov20 trial (abstract #6000), which demonstrated a clear survival benefit from secondary cytoreductive surgery in recurrent ovarian cancer. Read more here.
Software, Consulting and Workshops for Data Analysis and Model-Based Decision Support
Contract Manufacturing Organisation and Pharmaceutical Supply Services
Cloud-Based Off-the-Shelf Clinical Metadata Repository and Clinical Trial Automation Software Platform